Tamoxifen has a proliferative effect in endometrial carcinoma mediated via the GPER/EGFR/ERK/cyclin D1 pathway: A retrospective study and an in vitro studyLizhi Zhang, Ke Wen, Lan Lan et al.|Molecular and Cellular Endocrinology|2016Cited by 32